Oppenheimer Holdings Inc. (OPY)
After hours:
| Previous Close | 57.94 |
| Open | 56.79 |
| Bid | 53.21 x 2200 |
| Ask | 53.57 x 1400 |
| Day's Range | 52.26 - 56.55 |
| 52 Week Range | 32.82 - 58.35 |
| Volume | |
| Avg. Volume | 46,556 |
| Market Cap | 546.817M |
| Beta (5Y Monthly) | 1.14 |
| PE Ratio (TTM) | 14.16 |
| EPS (TTM) | 3.74 |
| Earnings Date | Oct 25, 2024 - Oct 29, 2024 |
| Forward Dividend & Yield | 0.60 (1.04%) |
| Ex-Dividend Date | May 09, 2024 |
| 1y Target Est | N/A |
CNW GroupOppenheimer Holdings Inc. Reports Second Quarter 2024 Earnings
Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024, compared with a net loss of $(9.4) million or $(0.85) basic earnings per share for the second quarter of 2023. Revenue for the second quarter of 2024 was $330.6 million, an increase of 8.0%, compared to revenue of $306.2 million for the second quarter of 2023.
PR NewswireOppenheimer Announces Additions to the High Yield and Distressed Debt Team
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —announced today the continued expansion of its Fixed Income Division with the addition of 10 more High Yield and Distressed Debt Team members.
PR NewswireOppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the appointment of Andreas Argyrides as Executive Director and Senior Analyst covering the Biotechnology sector.
